• Investors
    • Investor Centre
    • Live Investor Briefing
    • Share Price and Announcements
    • Corporate Governance
      • Directory & Advisers
      • Corporate Documents
      • Board Committees & responsibilities
    • AIM Rule 26
  • About Us
  • News & media
    • Webcast Replays
  • Contact
  • Investors
    • Investor Centre
    • Live Investor Briefing
    • Share Price and Announcements
    • Corporate Governance
      • Directory & Advisers
      • Corporate Documents
      • Board Committees & responsibilities
    • AIM Rule 26
  • About Us
  • News & media
    • Webcast Replays
  • Contact
Happy family: mother, father, children son and  daughter on nature  on sunset

Company news: Emyria; Wellnex Life; Neurotech International; Melodiol Global Health

Emyria has announced a number of changes to its board as the ASX-listed firm looks...

36412-wnx-1280x720-800x430

Financial results: Avecho; Wellnex; Zelira; Emyria; Botanix; MGC Pharma; AusCann; Epsilon; Melodiol; Bioxyne

Avecho Biotechnology saw revenue from ordinary activities fall 41% to A$446k in the half year...

36412-wnx-1280x720-800x430

Wellnex Life snaps up topical pain relief brand to complement medicinal cannabis strategy

ASX-listed Wellnex Life has entered into a binding agreement to acquire topical pain relief brand...

Releaf-Group-1

Company news: Releaf Group; Bod; Wellnex Life; MGC Pharma; MediCann Health

Cannabis franchise Releaf Group has opened expressions of interest (EOI) to acquire its New Zealand...

Releaf-Group-1

Company news: Releaf Group; Wellnex Life; MGC Pharma; MediCann Health

Cannabis franchise Releaf Group has opened expressions of interest (EOI) to acquire its New Zealand...

chemist-scaled

Wellnex warns of ‘limited shelf space’ as firm lays groundwork for OTC launch

Wellnex Life has spoken of the opportunities of the over-the-counter CBD market but warned there...

man running

Company news: Bod Australia; Cann Group; MediCann Health; MGC Pharma; Wellnex Life

Bod Australia has successfully raised A$2 million from new and existing shareholders to fund the acquisition...

RECENT POSTS
  • Wellnex Life reports improved cash flow and revenue growth in second quarter
  • Priceline Delivers Momentum for Wellnex
  • Wellnex Life (ASX:WNX) Investor Briefing with Ash Vesali – 1st December 2025
  • Wellnex Life (ASX:WNX) Q&A Zack Bozinovski – 30th May 2025
  • Wellnex Life – Interview with Zack Bozinovski
SHARE THIS POST
  • FB
  • Insta
  • Group 23
Home
About us
Contact us
Privacy Policy




*proposed new name change for Wattle Health Australia Limited (subject to shareholder approval)

This investor centre was built by Reach Markets

©2026 Reach Markets

×

Do you qualify as a Wholesale (708) investor?

Wholesale 708 Sophisticated Investors are individuals or entities who generally qualify under Sections 708(8) and s761G(7) of the Corporations Act based on the gross income and/or net assets test verified by a qualified accountant.
  • A gross income of $250,000 or more per annum in each of the previous two financial years; or
  • Net assets of at least $2.5 million; and
  • A verified Qualified Accountant’s certificate given no more than two (2) years ago confirming the Sophisticated Investor status. Please refer to the Corporations Act: Specifically Section 708(08) and Section s761G(7)